Search research articles
Contact Us
Filters
Showing results (71-80 of 111) with videos related to
Page
of 12
Sort By:
EJNMMI Physics
|
April 7, 2025
Open-source phantom with dedicated in-house software for image quality assurance in hybrid PET systems
Carmen Salvador-Ribés, Carina Soler-Pons, María Jesús Sánchez-García, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
October 16, 2025
First-in-Human PET Imaging of MT1-MMP in a Patient with Breast and Muscle-Invasive Urothelial Bladder Cancer Using the Bicyclic Radiotracer [<sup>68</sup>Ga]Ga-BCY25286
Ann-Christin Eder, Mohamed Aymen Omrane, Mohamed El Fakiri, et al.
Theranostics
|
August 2, 2021
Radiomics in prostate cancer imaging for a personalized treatment approach - current aspects of methodology and a systematic review on validated studies
Simon K B Spohn, Alisa S Bettermann, Fabian Bamberg, et al.
Clinical and Translational Radiation Oncology
|
March 4, 2022
The value of plasma hypoxia markers for predicting imaging-based hypoxia in patients with head-and-neck cancers undergoing definitive chemoradiation
Alexander Rühle, Anca-L Grosu, Nicole Wiedenmann, et al.
Cancers
|
March 6, 2021
FDG-PET Radiomics for Response Monitoring in Non-Small-Cell Lung Cancer Treated with Radiation Therapy
Montserrat Carles, Tobias Fechter, Gianluca Radicioni, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
June 10, 2026
First-in-human EphA2-targeting PET imaging with the bicyclic radiotracer [<sup>68</sup>Ga]Ga-BCY18469 in pancreatic cancer patients: biodistribution, dosimetry and initial findings
Ann-Christin Eder, Christoph-Ferdinand Wielenberg, Mohamed Aymen Omrane, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
June 17, 2020
The utility of multiparametric MRI to characterize hypoxic tumor subvolumes in comparison to FMISO PET/CT. Consequences for diagnosis and chemoradiation treatment planning in head and neck cancer
Nicole Wiedenmann, Anca-Ligia Grosu, Martin Büchert, et al.
Frontiers in Oncology
|
June 24, 2022
Risk Factors for Biochemical Recurrence After PSMA-PET-Guided Definitive Radiotherapy in Patients With <i>De Novo</i> Lymph Node-Positive Prostate Cancer
Simon K B Spohn, Viktoria Birkenmaier, Juri Ruf, et al.
Cancers
|
July 24, 2021
<sup>18</sup>F-FMISO-PET Hypoxia Monitoring for Head-and-Neck Cancer Patients: Radiomics Analyses Predict the Outcome of Chemo-Radiotherapy
Montserrat Carles, Tobias Fechter, Anca L Grosu, et al.
Theranostics
|
May 28, 2019
Radiomic features from PSMA PET for non-invasive intraprostatic tumor discrimination and characterization in patients with intermediate- and high-risk prostate cancer - a comparison study with histology reference
Constantinos Zamboglou, Montserrat Carles, Tobias Fechter, et al.
Page
of 12
Search research articles
Search
Showing results (71-80 of 111) with videos related to
Sort By:
Page
of 12
EJNMMI Physics
|
April 7, 2025
Open-source phantom with dedicated in-house software for image quality assurance in hybrid PET systems
Carmen Salvador-Ribés, Carina Soler-Pons, María Jesús Sánchez-García, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
October 16, 2025
First-in-Human PET Imaging of MT1-MMP in a Patient with Breast and Muscle-Invasive Urothelial Bladder Cancer Using the Bicyclic Radiotracer [<sup>68</sup>Ga]Ga-BCY25286
Ann-Christin Eder, Mohamed Aymen Omrane, Mohamed El Fakiri, et al.
Theranostics
|
August 2, 2021
Radiomics in prostate cancer imaging for a personalized treatment approach - current aspects of methodology and a systematic review on validated studies
Simon K B Spohn, Alisa S Bettermann, Fabian Bamberg, et al.
Clinical and Translational Radiation Oncology
|
March 4, 2022
The value of plasma hypoxia markers for predicting imaging-based hypoxia in patients with head-and-neck cancers undergoing definitive chemoradiation
Alexander Rühle, Anca-L Grosu, Nicole Wiedenmann, et al.
Cancers
|
March 6, 2021
FDG-PET Radiomics for Response Monitoring in Non-Small-Cell Lung Cancer Treated with Radiation Therapy
Montserrat Carles, Tobias Fechter, Gianluca Radicioni, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
June 10, 2026
First-in-human EphA2-targeting PET imaging with the bicyclic radiotracer [<sup>68</sup>Ga]Ga-BCY18469 in pancreatic cancer patients: biodistribution, dosimetry and initial findings
Ann-Christin Eder, Christoph-Ferdinand Wielenberg, Mohamed Aymen Omrane, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
June 17, 2020
The utility of multiparametric MRI to characterize hypoxic tumor subvolumes in comparison to FMISO PET/CT. Consequences for diagnosis and chemoradiation treatment planning in head and neck cancer
Nicole Wiedenmann, Anca-Ligia Grosu, Martin Büchert, et al.
Frontiers in Oncology
|
June 24, 2022
Risk Factors for Biochemical Recurrence After PSMA-PET-Guided Definitive Radiotherapy in Patients With <i>De Novo</i> Lymph Node-Positive Prostate Cancer
Simon K B Spohn, Viktoria Birkenmaier, Juri Ruf, et al.
Cancers
|
July 24, 2021
<sup>18</sup>F-FMISO-PET Hypoxia Monitoring for Head-and-Neck Cancer Patients: Radiomics Analyses Predict the Outcome of Chemo-Radiotherapy
Montserrat Carles, Tobias Fechter, Anca L Grosu, et al.
Theranostics
|
May 28, 2019
Radiomic features from PSMA PET for non-invasive intraprostatic tumor discrimination and characterization in patients with intermediate- and high-risk prostate cancer - a comparison study with histology reference
Constantinos Zamboglou, Montserrat Carles, Tobias Fechter, et al.
Page
of 12